GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,429.50p
   
  • Change Today:
    -20.00p
  • 52 Week High: 1,671.00p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,092.98m
  • Volume: 1,383,538
  • Market Cap: £58,509m
  • RiskGrade: 129

Latest Deals

Traded Action Notifier PriceAmountValue
10-Jun-25 Transfer From Julie Brown 0.000p 8 £0.00
10-Jun-25 Buy Julie Brown 1,265.04p 8 £101.20
10-Jun-25 Transfer From Emma Walmsley 0.000p 9 £0.00
10-Jun-25 Buy Emma Walmsley 1,265.04p 9 £113.85

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
10-Jun-25 Buy Emma Walmsley 1,265.04p 9 £113.85
10-Jun-25 Buy Julie Brown 1,265.04p 8 £101.20
10-Jun-25 Transfer From Emma Walmsley 0.000p 9 £0.00
10-Jun-25 Transfer From Julie Brown 0.000p 8 £0.00

Director Shareholdings

Notifier Holding Value*
Vishal Sikka 253,472,390 £3,623,387,815
Hal Barron 6,654,928 £95,132,196
Emma Walmsley 2,903,192 £41,501,130
Jonathan Symonds 66,543 £951,232
Charles Bancroft 56,221 £803,679
Julie Brown 44,359 £634,112
Anne Beal 6,447 £92,160
Harry (Hal) C. Dietz 5,080 £72,619
Elizabeth (Liz) McKee Anderson 3,688 £52,720
Jeannie Lee 2,054 £29,362
Wendy Becker 1,991 £28,461

Major Shareholders

Notifier** Holding Value*
Dodge & Cox 253,464,108 £3,623,269,424
Dodge & Cox 253,464,108 £3,623,269,424
BlackRock Inc 231,975,400 £3,316,088,343
GSK plc 197,068,169 £2,817,089,476
The Capital Group Companies, Inc. 159,068,073 £2,273,878,104
Legal & General Group Plc 95,878,187 £1,370,578,683

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,429.50p
Change Today -20.00p
% Change -1.38 %
52 Week High 1,671.00p
52 Week Low 1,264.00p
Volume 1,383,538
Shares Issued 4,092.98m
Market Cap £58,509m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.17% below the market average51.17% below the market average51.17% below the market average51.17% below the market average51.17% below the market average
39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average
Price Trend
21.90% above the market average21.90% above the market average21.90% above the market average21.90% above the market average21.90% above the market average
47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average
Income
72.57% above the market average72.57% above the market average72.57% above the market average72.57% above the market average72.57% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
34.02% below the market average34.02% below the market average34.02% below the market average34.02% below the market average34.02% below the market average
41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average41.94% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 19-Jun-2025

Time Volume / Share Price
11:40 0 @ 1,430.00p
11:40 0 @ 1,430.00p
11:40 139 @ 1,429.68p
11:40 5 @ 1,430.00p
11:40 690 @ 1,429.68p

GSK Key Personnel

CEO Emma Walmsley

Top of Page